Page 3 - Deepak Korgaonkar/workspace/business Standard Web/undefined

Vedanta stock trades ex-demerger, slips 7% from intra-day high

Vedanta remains firm on its deleveraging plans, and going forward, higher cash flows will support both its expansion plans and deleveraging efforts.

Adani Power gains 2% in weak market, zooms 49% in April; here's why

Adani Power reported strong PAT generation in Q4, driven by robust operating profitability and lower tax expenses.

Swiggy slips 3% on huge volumes; what's making the Street nervous?

The share price of Swiggy is quoting lower for a fifth straight trading day, falling 7.5 per cent during the period

Coal India up 4%; surpasses Vedanta, HAL, Power Grid in market cap ranking

Coal India is positioning for steady growth, supported by volume expansion and diversification into coal gasification, critical minerals, and renewable energy, say analysts.

Telecom stocks Bharti Airtel, Vodafone Idea gain up to 6% on huge volumes

Telecom players continue to gain market share, supported by higher customer stickiness, improving financial performance, and favourable market conditions.

Tyre stocks in demand: Ceat soars 12%; MRF, JK rally up to 6%; here's why

In Q4FY26, Ceat delivered high growth in all segments including international business, despite geopolitical tensions.

HCL Technologies, Infosys at 52-week lows; shares slide up to 17% in 1 week

Analysts believe HCL Technology's softer revenue guidance versus expectations and an AI deflation impact of 3-5% will likely raise concerns about overall industry growth for FY27.

Websol Energy Systems zooms 143% from March low; here's why

In the past one month, the stock price of Websol Energy Systems has rallied 88 per cent.

Two months of West Asia war: Analysts see smallcap's outperformance continuing

From their February 27, 2026, level, the Nifty Smallcap 100 index rallied 6.5 per cent, while the Nifty Midcap 100 index gained 2.2 per cent. In comparison, the Nifty 50 and BSE Sensex are still down.

Nestle India hits new high, soars 22% in 1 month; analysts see more upside

Strong position in the domestic foods market, innovative product portfolio, focus on distribution expansion and improving out-of-home consumption will help Nestle achieve better growth, say analysts.

Nifty PSU Bank slips 2%; Canara, BoI dip 3%; why are bank stocks falling?

The RBI has issued final guidelines for transitioning to an Expected Credit Loss (ECL) framework, effective April 1, 2027, largely in line with the earlier draft.

BHEL, SAIL hit multi-year highs, gain up to 39% in 1-mth; more upside left?

Analysts at JM Financial Institutional Securities have pegged an upside target of ₹393 per share on BHEL; whereas Axis Securities expects SAIL to rally toward ₹200-mark.

Adani Green, Adani Energy surge up to 56% in April; Time to book profit?

Analysts at ICICI Securities downgraded Adani Green and Adani Energy to 'Add' rating post Q4 results, citing a sharp rally in the share prices.

Sun Pharma rallies 6%, top gainer among Sensex stocks; here's why

Sun Pharma to acquire all outstanding shares of Organon for $14.00 per share in an all cash transaction with an enterprise valuation of $11.75 billion.

Aditya Birla Sun Life AMC hits new high, stock gains 5% post Q4 earnings

The company has traditionally been stronger on debt side while on equity side, it has consistently been losing market share for which the stock trades at a considerable discount to other larger peers.

Himadri Speciality surges 9%, hits 52-week high in weak market; here's why

Himadri Speciality said it has decided to remain firmly focused on disciplined capital allocation to drive sustainable returns and maintain a robust ROCE profile.

BHEL hits 14-year high, gains for 12th straight day; up 33% from OFS price

With healthy revenue growth, a strong order book, and a sustained execution pipeline, BHEL enters FY2026-27 with solid momentum.

Auto shares trades weak: M&M, TVS, Ashok Leyland down up to 4%; here's why

The Nifty Auto index has declined nearly 3% in the last two trading sessions amid a fresh spike in Brent oil prices owing to the US-Iran standoff.

Nifty Pharma index soars 3%; Dr Reddy's, Piramal Pharma rally up to 9%

Glenmark Pharma, Cipla, Wockhardt, Mankind Pharma, Lupin, Zydus Life, Laurus, Ipca Labs, Divis Labs, Strides Pharma and Onesource were up in the range of 3% to 6%.

Fujiyama Power up 68% from March low; Motilal Oswal initiates 'Buy' rating

The brokerage firm expects UTLSOLAR to deliver strong growth (56 per cent/65 per cent/65 per cent CAGR in revenue/EBITDA/PAT over FY25-28), driven by PMSGMBY-led demand and capacity expansion.